Contribution of neovascularization and intraplaque haemorrhage to atherosclerotic plaque progression and instability
暂无分享,去创建一个
A. Orekhov | D. Chistiakov | Y. Bobryshev | D. A. Chistiakov | A N Orekhov | Y V Bobryshev | D A Chistiakov | A. N. Orekhov
[1] M. Goumans,et al. Balance between Angiopoietin-1 and Angiopoietin-2 Is in Favor of Angiopoietin-2 in Atherosclerotic Plaques with High Microvessel Density , 2008, Journal of Vascular Research.
[2] H. Zentgraf,et al. Granzyme B is expressed in mouse mast cells in vivo and in vitro and causes delayed cell death independent of perforin , 2007, Cell Death and Differentiation.
[3] Paul Schoenhagen,et al. Plaque vulnerability, plaque rupture, and acute coronary syndromes: (multi)-focal manifestation of a systemic disease process. , 2002, Circulation.
[4] J. Eaton,et al. Hemin: a possible physiological mediator of low density lipoprotein oxidation and endothelial injury. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.
[5] P. Kovanen,et al. Cholesterol crystals activate the NLRP3 inflammasome in human monocytes and macrophages , 2010 .
[6] R. Virmani,et al. Free cholesterol in atherosclerotic plaques: where does it come from? , 2007, Current opinion in lipidology.
[7] Q. Gao,et al. Th17 cells and IL-17 are involved in the disruption of vulnerable plaques triggered by short-term combination stimulation in apolipoprotein E-knockout mice , 2013, Cellular and Molecular Immunology.
[8] David Zurakowski,et al. Inhibition of plaque neovascularization reduces macrophage accumulation and progression of advanced atherosclerosis , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[9] O. Wiklund,et al. Evidence of hypoxic areas within the arterial wall in vivo. , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[10] I. Loftus,et al. High Levels of Costimulatory Receptors OX40 and 4-1BB Characterize CD4+CD28null T Cells in Patients With Acute Coronary Syndrome , 2012, Circulation research.
[11] Mark M. Kockx,et al. Phagocytosis and Macrophage Activation Associated With Hemorrhagic Microvessels in Human Atherosclerosis , 2003, Arteriosclerosis, thrombosis, and vascular biology.
[12] R. Virmani,et al. Concept of vulnerable/unstable plaque. , 2010, Arteriosclerosis, thrombosis, and vascular biology.
[13] A. Levy,et al. Haptoglobin: basic and clinical aspects. , 2010, Antioxidants & redox signaling.
[14] P. Kovanen,et al. Chymase bound to heparin is resistant to its natural inhibitors and capable of proteolyzing high density lipoproteins in aortic intimal fluid. , 2001, Atherosclerosis.
[15] J. Paramo,et al. Vitamins C and E prevent endothelial VEGF and VEGFR-2 overexpression induced by porcine hypercholesterolemic LDL. , 2004, Cardiovascular research.
[16] R. Dean,et al. Cholesterol and oxysterol metabolism and subcellular distribution in macrophage foam cells. Accumulation of oxidized esters in lysosomes. , 2000, Journal of lipid research.
[17] W. J. Johnson,et al. Formation of cholesterol monohydrate crystals in macrophage-derived foam cells. , 1994, Journal of lipid research.
[18] Yun Zhang,et al. Haemin‐enhanced expression of haem oxygenase‐1 stabilizes erythrocyte‐induced vulnerable atherosclerotic plaques , 2010, British journal of pharmacology.
[19] A. Levy,et al. Pharmacogenomics in prevention of diabetic cardiovascular disease: utilization of the haptoglobin genotype in determining benefit from vitamin E , 2007, Expert review of cardiovascular therapy.
[20] Jian-Xiong Chen,et al. Disruption of Ang-1/Tie-2 Signaling Contributes to the Impaired Myocardial Vascular Maturation and Angiogenesis in Type II Diabetic Mice , 2008, Arteriosclerosis, thrombosis, and vascular biology.
[21] Alexis Lama T,et al. [Statins in acute coronary syndrome]. , 2008, Revista medica de Chile.
[22] R. Kurzrock,et al. Anti-vascular endothelial growth factor therapies and cardiovascular toxicity: what are the important clinical markers to target? , 2010, The oncologist.
[23] Jack Rubinstein,et al. The impact of circulating cholesterol crystals on vasomotor function: implications for no-reflow phenomenon. , 2011, JACC. Cardiovascular interventions.
[24] P. Kovanen,et al. Chymase in exocytosed rat mast cell granules effectively proteolyzes apolipoprotein AI-containing lipoproteins, so reducing the cholesterol efflux-inducing ability of serum and aortic intimal fluid. , 1996, The Journal of clinical investigation.
[25] P. E. Van den Steen,et al. Neutrophil gelatinase B potentiates interleukin-8 tenfold by aminoterminal processing, whereas it degrades CTAP-III, PF-4, and GRO-alpha and leaves RANTES and MCP-2 intact. , 2000, Blood.
[26] X. Puente,et al. LPS Responsiveness and Neutrophil Chemotaxis In Vivo Require PMN MMP-8 Activity , 2007, PloS one.
[27] L. R. Padial,et al. A Proteomic Focus on the Alterations Occurring at the Human Atherosclerotic Coronary Intima* , 2011, Molecular & Cellular Proteomics.
[28] Jason L. Johnson,et al. Matrix metalloproteinases: influence on smooth muscle cells and atherosclerotic plaque stability , 2007, Expert review of cardiovascular therapy.
[29] D. Bergqvist,et al. Intraplaque haemorrhage at carotid artery surgery ‐ a predictor of cardiovascular mortality , 1995, Journal of Internal Medicine.
[30] M. Soares,et al. Atherogenesis May Involve the Prooxidant and Proinflammatory Effects of Ferryl Hemoglobin , 2013, Oxidative medicine and cellular longevity.
[31] Helen X. Chen,et al. Adverse effects of anticancer agents that target the VEGF pathway , 2009, Nature Reviews Clinical Oncology.
[32] M. Mulligan-Kehoe. The vasa vasorum in diseased and nondiseased arteries. , 2010, American Journal of Physiology. Heart and Circulatory Physiology.
[33] M. Gerritsen,et al. Transfection of the human heme oxygenase gene into rabbit coronary microvessel endothelial cells: protective effect against heme and hemoglobin toxicity. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[34] F. Moll,et al. Platelets enter atherosclerotic plaque via intraplaque microvascular leakage and intraplaque hemorrhage: a histopathological study in carotid plaques. , 2012, Atherosclerosis.
[35] E. Ritman,et al. Antioxidant intervention prevents renal neovascularization in hypercholesterolemic pigs. , 2004, Journal of the American Society of Nephrology : JASN.
[36] S. Fukumoto,et al. Peroxisome Proliferator-Activated Receptor-γ Agonists Increase Vascular Endothelial Growth Factor Expression in Human Vascular Smooth Muscle Cells , 2000 .
[37] T. Akasaka,et al. Assessment of coronary atherosclerosis using optical coherence tomography. , 2014, Journal of atherosclerosis and thrombosis.
[38] I. Tentes,et al. Statin Use is Associated with a Significant Reduction in Cholesterol Content of Erythrocyte Membranes. A Novel Pleiotropic Effect? , 2009, Cardiovascular Drugs and Therapy.
[39] G. Franceschini,et al. Mast Cell Chymase Degrades ApoE and ApoA-II in ApoA-I–Knockout Mouse Plasma and Reduces Its Ability to Promote Cellular Cholesterol Efflux , 2002, Arteriosclerosis, thrombosis, and vascular biology.
[40] K. Aziz,et al. Cholesterol crystals rupture biological membranes and human plaques during acute cardiovascular events--a novel insight into plaque rupture by scanning electron microscopy. , 2006, Scanning.
[41] E. Raines,et al. Macrophage expression of active MMP-9 induces acute plaque disruption in apoE-deficient mice. , 2005, The Journal of clinical investigation.
[42] R. Frye,et al. Interleukin 12 Induces T-Cell Recruitment Into the Atherosclerotic Plaque , 2006, Circulation research.
[43] J. Eaton,et al. Heme, heme oxygenase and ferritin in vascular endothelial cell injury. , 2005, Molecular nutrition & food research.
[44] R. Califf,et al. Effect of lipid-lowering therapy on early mortality after acute coronary syndromes: an observational study , 2001, The Lancet.
[45] S. Kaul,et al. Membrane type 1 matrix metalloproteinase expression in human atherosclerotic plaques: evidence for activation by proinflammatory mediators. , 1999, Circulation.
[46] Constance E. Brinckerhoff,et al. Matrix metalloproteinases: a tail of a frog that became a prince , 2002, Nature Reviews Molecular Cell Biology.
[47] F. Altruda,et al. Hemopexin: structure, function, and regulation. , 2002, DNA and cell biology.
[48] W. Liles,et al. The phagocytes: neutrophils and monocytes. , 2008, Blood.
[49] A. Levy,et al. The genetics of vascular complications in diabetes mellitus. , 2010, Cardiology clinics.
[50] J. Alam,et al. Heme-hemopexin-mediated induction of metallothionein gene expression. , 1992, The Journal of biological chemistry.
[51] S. Gabriel,et al. B-Lymphocytes in plaque and adventitia of coronary arteries in two patients with rheumatoid arthritis and coronary atherosclerosis: preliminary observations. , 2004, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.
[52] J. Stark,et al. Coronary intraplaque hemorrhage evokes a novel atheroprotective macrophage phenotype. , 2009, The American journal of pathology.
[53] W. Shimizu,et al. Relationship between cholesterol crystals and culprit lesion characteristics in patients with stable coronary artery disease: an optical coherence tomography study , 2014, Clinical Research in Cardiology.
[54] P. Kovanen,et al. Mast cells in vulnerable coronary plaques: potential mechanisms linking mast cell activation to plaque erosion and rupture , 2004, Current opinion in lipidology.
[55] V. Hasselblad,et al. Benefit of Glycoprotein IIb/IIIa Inhibition in Patients With Acute Coronary Syndromes and Troponin T–Positive Status: The PARAGON-B Troponin T Substudy , 2001, Circulation.
[56] Claudio Napoli,et al. Antioxidant Intervention Attenuates Myocardial Neovascularization in Hypercholesterolemia , 2004, Circulation.
[57] R. Virmani,et al. Hemoglobin directs macrophage differentiation and prevents foam cell formation in human atherosclerotic plaques. , 2012, Journal of the American College of Cardiology.
[58] P. Libby,et al. Evidence for increased collagenolysis by interstitial collagenases-1 and -3 in vulnerable human atheromatous plaques. , 1999, Circulation.
[59] G. Liuzzo. Unusual CD4 CD28 T Lymphocytes and Recurrence of Acute Coronary Events , 2007 .
[60] R. Goldbach-Mansky,et al. IL-1 blockade in autoinflammatory syndromes. , 2014, Annual review of medicine.
[61] M. Bäck,et al. The Role of Matrix Metalloproteinases in Atherothrombosis , 2011, Current atherosclerosis reports.
[62] C. Alpers,et al. Neovascular expression of E-selectin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in human atherosclerosis and their relation to intimal leukocyte content. , 1996, Circulation.
[63] P. Serruys,et al. Coronary stents: historical development, current status and future directions. , 2013, British medical bulletin.
[64] M. Chiariello,et al. Patients With Acute Coronary Syndrome Show Oligoclonal T-Cell Recruitment Within Unstable Plaque: Evidence for a Local, Intracoronary Immunologic Mechanism , 2006, Circulation.
[65] E. Ritman,et al. Increased spatial vasa vasorum density in the proximal LAD in hypercholesterolemia--implications for vulnerable plaque-development. , 2007, Atherosclerosis.
[66] P. Libby,et al. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. , 1994, The Journal of clinical investigation.
[67] A. Meyrier. Cholesterol crystal embolism: diagnosis and treatment. , 2006, Kidney international.
[68] K. Kanmatsuse,et al. [Pathogenesis of acute coronary syndromes]. , 1998, Nihon rinsho. Japanese journal of clinical medicine.
[69] D. Böckler,et al. The expression of glycophorin A and osteoprotegerin is locally increased in carotid atherosclerotic lesions of symptomatic compared to asymptomatic patients. , 2013, International journal of molecular medicine.
[70] M. Mayr,et al. The paradox of hypoxic and oxidative stress in atherosclerosis. , 2008, Journal of the American College of Cardiology.
[71] D. Woolley,et al. Mast cell proteinases activate precursor forms of collagenase and stromelysin, but not of gelatinases A and B. , 1994, European journal of biochemistry.
[72] Z. Motovska,et al. Stent thrombosis--risk assessment and prevention. , 2010, Cardiovascular therapeutics.
[73] P. Harrison,et al. Structure, function, and evolution of ferritins. , 1992, Journal of inorganic biochemistry.
[74] D. Agrawal,et al. MMP‐1 and MMP‐9 regulate epidermal growth factor‐dependent collagen loss in human carotid plaque smooth muscle cells , 2014, Physiological reports.
[75] P. Libby,et al. An HMG-CoA Reductase Inhibitor, Cerivastatin, Suppresses Growth of Macrophages Expressing Matrix Metalloproteinases and Tissue Factor In Vivo and In Vitro , 2001, Circulation.
[76] J. Eaton,et al. Heme, heme oxygenase, and ferritin: how the vascular endothelium survives (and dies) in an iron-rich environment. , 2007, Antioxidants & redox signaling.
[77] J. Michel,et al. Involvement of intraplaque hemorrhage in atherothrombosis evolution via neutrophil protease enrichment , 2007, Journal of leukocyte biology.
[78] P. Douek,et al. In Vivo Magnetic Resonance Imaging of Large Spontaneous Aortic Aneurysms in Old Apolipoprotein E-Deficient Mice , 2004, Investigative radiology.
[79] P. Escribá,et al. Regulation of heme oxygenase and metallothionein gene expression by the heme analogs, cobalt-, and tin-protoporphyrin. , 1993, The Journal of biological chemistry.
[80] Yong Chen,et al. The Th17/Treg imbalance in patients with acute coronary syndrome. , 2008, Clinical immunology.
[81] N. Shaklai,et al. Oxidative crosslinking of LDL protein induced by hemin: involvement of tyrosines. , 1994, Biochemistry and molecular biology international.
[82] Yoon K Loke,et al. Long-term risk of cardiovascular events with rosiglitazone: a meta-analysis. , 2007, JAMA.
[83] P. Carmeliet,et al. Immaturity of microvessels in haemorrhagic plaques is associated with proteolytic degradation of angiogenic factors. , 2010, Cardiovascular research.
[84] E L Ritman,et al. Enhanced coronary vasa vasorum neovascularization in experimental hypercholesterolemia. , 1998, The Journal of clinical investigation.
[85] Chun Yuan,et al. Presence of Intraplaque Hemorrhage Stimulates Progression of Carotid Atherosclerotic Plaques: A High-Resolution Magnetic Resonance Imaging Study , 2005, Circulation.
[86] Renu Virmani,et al. Thin-walled microvessels in human coronary atherosclerotic plaques show incomplete endothelial junctions relevance of compromised structural integrity for intraplaque microvascular leakage. , 2009, Journal of the American College of Cardiology.
[87] E. Ritman,et al. Coronary vasa vasorum neovascularization precedes epicardial endothelial dysfunction in experimental hypercholesterolemia. , 2001, Cardiovascular research.
[88] G. Doronzo,et al. C-reactive protein increases matrix metalloproteinase-2 expression and activity in cultured human vascular smooth muscle cells. , 2005, The Journal of laboratory and clinical medicine.
[89] P. Heeringa,et al. Internalization of proteinase 3 is concomitant with endothelial cell apoptosis and internalization of myeloperoxidase with generation of intracellular oxidants. , 2001, The American journal of pathology.
[90] A. Naylor,et al. Carotid plaque instability and ischemic symptoms are linked to immaturity of microvessels within plaques. , 2007, Journal of vascular surgery.
[91] A. Becker,et al. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. , 1994, Circulation.
[92] J. Kassirer. Atheroembolic renal disease. , 1969, The New England journal of medicine.
[93] Egil Lien,et al. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals , 2010, Nature.
[94] B. Roelofsen,et al. Kinetics and site specificity of hydroperoxide-induced oxidative damage in red blood cells. , 1992, Free radical biology & medicine.
[95] R. de Caterina,et al. Statins inhibit cyclooxygenase-2 and matrix metalloproteinase-9 in human endothelial cells: anti-angiogenic actions possibly contributing to plaque stability. , 2010, Cardiovascular research.
[96] C. Vahl,et al. Subendothelial infiltration of neutrophil granulocytes and liberation of matrix-destabilizing enzymes in an experimental model of human neo-intima , 2008, Thrombosis and Haemostasis.
[97] M. Shintaku,et al. Distribution of inflammatory cells in adventitia changed with advancing atherosclerosis of human coronary artery. , 2007, Journal of atherosclerosis and thrombosis.
[98] Mathijs Groeneweg,et al. Hypoxia, hypoxia-inducible transcription factor, and macrophages in human atherosclerotic plaques are correlated with intraplaque angiogenesis. , 2008, Journal of the American College of Cardiology.
[99] A. Maseri,et al. Expansion of T-Cell Receptor &zgr;dim Effector T Cells in Acute Coronary Syndromes , 2008, Arteriosclerosis, thrombosis, and vascular biology.
[100] A. Newby,et al. Statins Inhibit Secretion of Metalloproteinases-1, -2, -3, and -9 From Vascular Smooth Muscle Cells and Macrophages , 2003, Arteriosclerosis, thrombosis, and vascular biology.
[101] K. Matsubara,et al. Phosphatidylcholine hydroperoxide promotes VEGF-induced angiogenesis in endothelial cells and rat aorta ring cultures. , 2011, Biochimica et biophysica acta.
[102] Michael E. Hall,et al. Matrix metalloproteinase-9: Many shades of function in cardiovascular disease. , 2013, Physiology.
[103] A. Orekhov,et al. Vascular Extracellular Matrix in Atherosclerosis , 2013, Cardiology in review.
[104] Y. L. Chen,et al. Increased ferritin gene expression in atherosclerotic lesions. , 1996, The Journal of clinical investigation.
[105] S. Husson,et al. Gelatinase B/MMP-9 and neutrophil collagenase/MMP-8 process the chemokines human GCP-2/CXCL6, ENA-78/CXCL5 and mouse GCP-2/LIX and modulate their physiological activities. , 2003, European journal of biochemistry.
[106] J. Michel,et al. From intraplaque haemorrhages to plaque vulnerability: biological consequences of intraplaque haemorrhages , 2012, Journal of cardiovascular medicine.
[107] V. Fuster,et al. Macrophages Transmit Potent Proangiogenic Effects of oxLDL In Vitro and In Vivo Involving HIF-1α Activation: a Novel Aspect of Angiogenesis in Atherosclerosis , 2013, Journal of Cardiovascular Translational Research.
[108] X. Filella,et al. Vascular endothelial growth factor serum concentrations in hypercholesterolemic patients , 2006, Scandinavian journal of clinical and laboratory investigation.
[109] J. Jukema,et al. Lesional Overexpression of Matrix Metalloproteinase-9 Promotes Intraplaque Hemorrhage in Advanced Lesions But Not at Earlier Stages of Atherogenesis , 2005, Arteriosclerosis, thrombosis, and vascular biology.
[110] P. Libby,et al. Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion. , 1994, Circulation research.
[111] K. Varani,et al. Adenosine Modulates HIF-1&agr;, VEGF, IL-8, and Foam Cell Formation in a Human Model of Hypoxic Foam Cells , 2010, Arteriosclerosis, thrombosis, and vascular biology.
[112] J. Fernandes,et al. Characterization of CD4+CD28null T cells in patients with coronary artery disease and individuals with risk factors for atherosclerosis. , 2013, Cellular immunology.
[113] K. Aziz,et al. Effect of cholesterol crystals on plaques and intima in arteries of patients with acute coronary and cerebrovascular syndromes. , 2009, The American journal of cardiology.
[114] P. Libby,et al. Macrophage foam cells from experimental atheroma constitutively produce matrix-degrading proteinases. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[115] B. Kou,et al. Effects of cyclic strain on endothelial cell apoptosis and tubulogenesis are dependent on ROS production via NAD(P)H subunit p22phox. , 2009, Microvascular research.
[116] S. Fukumoto,et al. Peroxisome proliferator-activated receptor-gamma agonists increase vascular endothelial growth factor expression in human vascular smooth muscle cells. , 2000, Biochemical and biophysical research communications.
[117] K. Berger,et al. Plaque Rupture and Thrombosis Are Reduced by Lowering Cholesterol Levels and Crystallization With Ezetimibe and Are Correlated With Fluorodeoxyglucose Positron Emission Tomography , 2011, Arteriosclerosis, thrombosis, and vascular biology.
[118] J. Boyle. Heme and haemoglobin direct macrophage Mhem phenotype and counter foam cell formation in areas of intraplaque haemorrhage , 2012, Current opinion in lipidology.
[119] J. Michel,et al. The phosphatidylserine receptor mediates phagocytosis by vascular smooth muscle cells , 2007, The Journal of pathology.
[120] J. Eaton,et al. Red Cells, Hemoglobin, Heme, Iron, and Atherogenesis , 2010, Arteriosclerosis, thrombosis, and vascular biology.
[121] F. Moll,et al. High Neutrophil Numbers in Human Carotid Atherosclerotic Plaques Are Associated With Characteristics of Rupture-Prone Lesions , 2010, Arteriosclerosis, thrombosis, and vascular biology.
[122] S. Weiss,et al. Activation of the endogenous metalloproteinase, gelatinase, by triggered human neutrophils. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[123] Chunhong Ma,et al. IL-17 induces apoptosis of vascular endothelial cells: a potential mechanism for human acute coronary syndrome. , 2011, Clinical immunology.
[124] A. Dembińska-kieć,et al. Ligands of peroxisome proliferator-activated receptor-gamma increase the generation of vascular endothelial growth factor in vascular smooth muscle cells and in macrophages. , 2000, Acta biochimica Polonica.
[125] G. Biondi-Zoccai,et al. Interleukin-1 blockade with anakinra to prevent adverse cardiac remodeling after acute myocardial infarction (Virginia Commonwealth University Anakinra Remodeling Trial [VCU-ART] Pilot study). , 2010, The American journal of cardiology.
[126] Antonius F. W. van der Steen,et al. Molecular imaging of inflammation and intraplaque vasa vasorum: A step forward to identification of vulnerable plaques? , 2010, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.
[127] Jean-Baptiste Michel,et al. Topological Determinants and Consequences of Adventitial Responses to Arterial Wall Injury , 2007, Arteriosclerosis, thrombosis, and vascular biology.
[128] K. Moulton. Angiogenesis in atherosclerosis: gathering evidence beyond speculation , 2006, Current opinion in lipidology.
[129] J. Burke,et al. Statins alter neutrophil migration by modulating cellular Rho activity—a potential mechanism for statins‐mediated pleotropic effects? , 2008, Journal of leukocyte biology.
[130] Toshihiro Kobayashi,et al. Neutrophil infiltration and oxidant-production in human atherosclerotic carotid plaques. , 2011, Histology and histopathology.
[131] F. Sellke,et al. High-Dose Atorvastatin Improves Hypercholesterolemic Coronary Endothelial Dysfunction Without Improving the Angiogenic Response , 2006, Circulation.
[132] 柚木 佳. Enhanced expression of haemoglobin scavenger receptor in accumulated macrophages of culprit lesions in acute coronary syndromes , 2011 .
[133] Wouter Peeters,et al. Composition of Carotid Atherosclerotic Plaque Is Associated With Cardiovascular Outcome: A Prognostic Study , 2010, Circulation.
[134] R. de Leeuw,et al. Nonsteroidal anti-inflammatory drugs and antihypertensives: how do they relate? , 2014, Oral surgery, oral medicine, oral pathology and oral radiology.
[135] Huixia Lu,et al. Pathological mechanisms of erythrocyte-induced vulnerability of atherosclerotic plaques. , 2008, Medical hypotheses.
[136] A. Balbarini,et al. Angiogenesis as risk factor for plaque vulnerability. , 2009, Current pharmaceutical design.
[137] E. Ritman,et al. Low vasa vasorum densities correlate with inflammation and subintimal thickening: potential role in location--determination of atherogenesis. , 2009, Atherosclerosis.
[138] P. Kovanen. Mast cells: multipotent local effector cells in atherothrombosis , 2007, Immunological reviews.
[139] Renu Virmani,et al. Intraplaque hemorrhage and progression of coronary atheroma. , 2003, The New England journal of medicine.
[140] F. Crea,et al. Anti-inflammatory treatment of acute coronary syndromes. , 2011, Current pharmaceutical design.
[141] G. Bergström,et al. Consistent differences in protein distribution along the longitudinal axis in symptomatic carotid atherosclerotic plaques. , 2010, Biochemical and biophysical research communications.
[142] R. Frye,et al. T-Cell–Mediated Lysis of Endothelial Cells in Acute Coronary Syndromes , 2002, Circulation.
[143] K. Walsh,et al. Statin therapy and angiogenesis , 2003, Current opinion in lipidology.
[144] K. Moore,et al. NLRP3 inflamasomes are required for atherogenesis and activated by cholesterol crystals that form early in disease , 2010, Nature.
[145] Y. Bobryshev,et al. Neovascular expression of VE-cadherin in human atherosclerotic arteries and its relation to intimal inflammation. , 1999, Cardiovascular research.
[146] A. Rebuzzi,et al. Unusual CD4+CD28nullT Lymphocytes and Recurrence of Acute Coronary Events , 2007 .
[147] Kayoko Sato,et al. T Cell Recognition and Killing of Vascular Smooth Muscle Cells in Acute Coronary Syndrome , 2006, Circulation research.
[148] I. Mitroulis,et al. Targeting IL-1beta in disease; the expanding role of NLRP3 inflammasome. , 2010, European journal of internal medicine.
[149] G. Biondi-Zoccai,et al. Effects of interleukin-1 blockade with anakinra on adverse cardiac remodeling and heart failure after acute myocardial infarction [from the Virginia Commonwealth University-Anakinra Remodeling Trial (2) (VCU-ART2) pilot study]. , 2013, The American journal of cardiology.
[150] J. Aschner,et al. Overexpression of angiopoietin-2 impairs myocardial angiogenesis and exacerbates cardiac fibrosis in the diabetic db/db mouse model. , 2012, American journal of physiology. Heart and circulatory physiology.
[151] E. Ritman,et al. Simvastatin Preserves the Structure of Coronary Adventitial Vasa Vasorum in Experimental Hypercholesterolemia Independent of Lipid Lowering , 2002, Circulation.
[152] Juan J. Badimon,et al. Plaque Neovascularization Is Increased in Ruptured Atherosclerotic Lesions of Human Aorta: Implications for Plaque Vulnerability , 2004, Circulation.
[153] Gieri Cathomas,et al. Arterial Neovascularization and Inflammation in Vulnerable Patients: Early and Late Signs of Symptomatic Atherosclerosis , 2004, Circulation.
[154] L. Lerman,et al. Prevention of vasa vasorum neovascularization attenuates early neointima formation in experimental hypercholesterolemia , 2009, Basic Research in Cardiology.
[155] V. Fuster,et al. Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques. Potential role of matrix-degrading metalloproteinases and implications for plaque rupture. , 1995, Circulation.
[156] Huixia Lu,et al. Pathological mechanisms and dose dependency of erythrocyte-induced vulnerability of atherosclerotic plaques. , 2007, Journal of molecular and cellular cardiology.
[157] Qingbo Xu,et al. Heat-Shock Protein 60-Reactive CD4+CD28null T Cells in Patients With Acute Coronary Syndromes , 2004, Circulation.
[158] T. Paavonen,et al. Association between myocardial infarction and the mast cells in the adventitia of the infarct-related coronary artery. , 1999, Circulation.
[159] J. Kaski,et al. CD4+ CD28 null T cells in coronary artery disease: when helpers become killers. , 2009, Cardiovascular research.
[160] Ruiping Huang,et al. Effect of statins on cholesterol crystallization and atherosclerotic plaque stabilization. , 2011, The American journal of cardiology.
[161] Qingbo Xu,et al. Heat-Shock Protein 60 – Reactive CD 4 CD 28 null T Cells in Patients With Acute Coronary Syndromes , 2004 .
[162] Jean-Baptiste Michel,et al. Intraplaque haemorrhages as the trigger of plaque vulnerability , 2011, European heart journal.
[163] F. Loffredo,et al. C-reactive protein induces expression of matrix metalloproteinase-9: a possible link between inflammation and plaque rupture. , 2013, International journal of cardiology.
[164] J. Yodoi,et al. Thioredoxin in coronary culprit lesions: possible relationship to oxidative stress and intraplaque hemorrhage. , 2008, Atherosclerosis.
[165] J. Waltenberger,et al. High-dose atorvastatin is associated with impaired myocardial angiogenesis in response to vascular endothelial growth factor in hypercholesterolemic swine: relevance to the human situation? , 2007, The Journal of thoracic and cardiovascular surgery.
[166] R. Frye,et al. Monoclonal T-cell proliferation and plaque instability in acute coronary syndromes. , 2000, Circulation.
[167] Aloke V. Finn,et al. Atherosclerotic Plaque Progression and Vulnerability to Rupture: Angiogenesis as a Source of Intraplaque Hemorrhage , 2005, Arteriosclerosis, thrombosis, and vascular biology.
[168] P R Bell,et al. Angiogenesis and the atherosclerotic carotid plaque: association between symptomatology and plaque morphology , 1999, Journal of vascular surgery.
[169] M. Gilard,et al. Surgical angioplasty with exclusion of atheromatous plaques in case of diffuse disease of the left anterior descending artery: 2 years' follow-up. , 2000, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[170] Chao Zhang,et al. Relationship between Enhanced Intensity of Contrast Enhanced Ultrasound and Microvessel Density of Aortic Atherosclerostic Plaque in Rabbit Model , 2014, PloS one.
[171] J. Montero,et al. Intravitreal inserts of steroids to treat diabetic macular edema. , 2009, Current diabetes reviews.